Revamping the distribution network

Revamping the distribution network
The pharmaceuticals distribution business in the country is all set for a revolution. VAT, consolidation of pharma companies, and emergence of pharma retail chains are some factors that will drive the change in the distribution cycle, discovers Sapna Dogra

Indian biotech dreams come true
Biotech is the buzzword of the decade. The year 2005 saw a robust growth in the global biotech sector with Asia Pacific countries achieving cumulative profitability. But 2006 has a lot more to offer.

Hot Right Now

Biocon launches a new biologics facility
Biotech major, Biocon has launched India’s largest multi-product biologics facility, Biocon Biopharmaceuticals, at Biocon Park in Bommasandra industrial area. The Finance Minister, P Chidambaram, inaugurated the facility.

Roche launches Tarceva for lung cancer
Roche Scientific Company announced that the innovative drug, Tarceva (erlotinib) will be available in India. Tarceva brings a glimmer of hope to Indians suffering from lung cancer.

Godrej Aadhaar ties up with Apollo
Godrej Aadhaar, the rural services cum retail initiative of Godrej Agrovet, signed an agreement with Apollo Pharmacy to offer medicine support across Godrej Aadhaar outlets in rural India. Apollo Pharmacy is a part of the Apollo Hospitals group and India’s largest retail pharmacy chain.

GSK launches launches ENO Pudina
GlaxoSmithKline Consumer Healthcare (GSKCH) has announced the introduction of ENO Pudina. With the launch of the pudina flavoured variant, the company has expanded its portfolio of products in the antacids segment.

Ranbaxy counters R&D hive-off report
Ranbaxy Laboratories is considering a plan to spin off its R&D unit, according to a newspaper report. But India’s second-most-valuable drug maker said that the report did not reflect the “true situation”.

Zydus Cadila receives tentative approval for Levofloxacin
Zydus Cadila has received tentative approval from the USFDA to market Levofloxacin Tablets, 250 mg, 500 mg and 750 mg in the US market. The drug falls in the anti-infective segment.

Plethico Pharmaceuticals IPO subscribed 25.63 times
Plethico Pharmaceuticals has closed its IPO and has been subscribed 25.63 times. The issue was through 100 percent book-built route.

‘Spotlight is too much on pharmaceuticals’
Right environment ushers good opportunities. The informal talk organised between Pharmaceutical Research and Manufacturers of America (PhRMA) association representatives was meant to recognise this environment and opportunities that PhRMA anticipates in the buzzing Indian pharma industry.

Enterprise control system by Invensys
A new technology is in, every day and here it is again. Invensys Process Systems has come up with a new Infusion enterprise control system. The system will help industrial enterprises more effectively align plant operations and maintenance departments with the business.

Chemspec India 2006
Chemspec India 2006, India’s premier international exhibition on fine and specialty chemicals was held in Mumbai recently. Chemspec India, after the resounding success in Hyderabad in 2005, was organised by DMG World Media (UK), publishers of Specialty Chemicals, in association with Chemical Weekly.